University of California San Francisco
Give to UCSF
The team behind a K Scholar Team Science Award designed a pilot study to shine light on fertility after liver transplant and the subsequent need for improved family planning counseling.
A study showed ongoing regional geographic variations in liver transplant rates for ALD patients, whose long-term survival rate is slightly lower than other liver transplant patients.
UCSF ranked sixth on the national Best Hospitals Honor Roll and received special recognition for exceptional performance in 15 medical specialties, including top-10 status in a dozen.
UCSF researchers discovered fully formed gut and skin cells in the thymus, the organ responsible for training the T cells of the immune system not to attack the body’s own tissues.
Experiments using parasitic worms in the mouse gut have revealed a surprising new form of wound repair, a finding that could help scientists develop ways to enhance the body’s natural healing abilities.
A UCSF researcher is among scientists who discovered the specific bacterial enzyme found in the human gut that can render a common heart drug ineffective.
By studying a rare liver disease called Alagille syndrome, scientists from UC San Francisco and Cincinnati Children’s Hospital Medical Center have discovered the mechanism behind an unusual form of tissue regeneration that may someday reduce the need for expensive and difficult-to-obtain organ transplants.
Researchers at UCSF have identified specific gut microbes associated with MS in human patients, showing that these microbes take part in regulating immune responses in mouse models of the disease.
An experimental diet that cut out a type of sugar significantly reversed the buildup of liver fat in children and adolescents – a condition strongly linked to Type 2 diabetes and cardiovascular disease.
A study headed by UCSF researchers fuels the probiotics debate by finding that there is no clear evidence that a supplement of the “friendly” bacteria strain of lactobacillus prevents eczema.
A virus hiding quietly in the gut may trigger the onset of a severe complication known as graft-versus-host disease (GvHD) in patients who receive bone marrow transplants.
Specialized cells in the gut sense potentially noxious chemicals and trigger electrical impulses in nearby nerve fibers, according to a new study led by UCSF scientists.
Nearly half of the patients in a safety net health system who had an abnormal stool-based screening test for colorectal cancer failed to receive the recommended colonoscopy within a year.
